
Pharma Weekly Updates in a Quick, 2-Minute Read.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 166 | Founded | 3 years ago | Last Issue | 7 days ago |
| Active | |||||

🤝 AstraZeneca and Bristol Myers Squibb were reportedly exploring a ~$400B megamerger, but a senior source later said no discussions were ongoing, cooling speculation over one of pharma’s largest potential combinations.
✂️ Pfizer expan...
🤝 argenx will acquire Forte Biosciences, Inc. for about $2.2B, adding FB102, a first-in-class anti-CD122 antibody with clinical validation in vitiligo and celiac disease.
✂️ GSK launched a 3-year restructuring plan to save about £1.9B...
🟢 GSK won FDA approval for Jideytro in advanced lung cancer, marking its 1st lung cancer approval, a significant cancer-treatment advance.
🤖 Insilico Medicine says its AI-driven platform now reaches drug candidates in 13 months versus 4....
🤝Eli Lilly and Company will acquire AtaiBeckley for up to $3.8B, adding a nasal psychedelic for treatment-resistant depression and expanding its neuropsychiatry pipeline.
💰 Agenus raised $340M to pivot BOT+BAL development from late-line...
🤝 Vertex Pharmaceuticals will buy Crinetics Pharmaceuticals for $10B, its largest acquisition ever, expanding into endocrinology with Palsonify.
💊 Kailera Therapeutics’s obesity pill succeeded in a late-stage China trial, producing a...
Subscribers, engagement, traffic and sponsorship for \ud83d\udd2c Latest Pharma Industry Updates.
| Subscribers | Engagement | 70 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #232 |
The writers behind this newsletter.
Pharma Senior Market Analyst providing weekly updates about the Life science industry.
You can find recent issues that have been published by this newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to this newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch this newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact this newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like this newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.